Ray Trumbo

Ray Trumbo

Ray’s Company

Novartis

Website: http://www.novartis.com

Twitter: @novartis

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a ... More » Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In 2008, the GroupÂ’s continuing operations achieved net sales of USD 41.5 billion and net income of USD 8.2 billion. Approximately USD 7.2 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 99,000 full-time-equivalent associates and operate in more than 140 countries around the world. Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland, ranking number two in sales (46.806 billion US$) among the world-wide industry in 2010. Novartis manufactures such drugs as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include cyclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. In 1996 Ciba-Geigy merged with Sandoz, with the pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were sold off, or, like Ciba Specialty Chemicals, were spun off as independent companies. The Sandoz brand disappeared for 3 years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta, in partnership with AstraZeneca which also divested its agrochemical business. Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA). [ CrunchBase ]

India's rejection of drug patent could reverberate - News9.com - Oklahoma City, OK - News, Weather,...

Not only Novartis, I don't think any global company is planning to research in India," Ranjit Shahani, the vice chairman and managing director of Novartis India, said after the ruling. Erik Gordon, a professor and analyst at University of Michigan's Ross School of Business, agrees. He ...

Ranjit Shahani

Mentioned in this article:
Ranjit Shahani

U.S. sues Novartis over kickbacks - Yahoo! News

Novartis - Novartis spokeswoman Julie Masow said the company disputes the claims in both lawsuits and will defend itself. She also said physician speaker programs are "an accepted and customary practice" in the industry. People who file whistleblower lawsuits, sometimes known as "qui tam" lawsuits...

Julie Masow

Mentioned in this article:
Julie Masow

Novartis sued by US states over alleged kickbacks to pharmacy firm - The Economic Times

"The company disputes the allegations made by the Attorney General for the State of New York related to Novartis Pharmaceutical Company's (NPC) interactions with specialty pharmacy BioScrip and intends to defend itself in this litigation," Andre Wyss, NPC President, said in an emailed ...

Andre Wyss

Mentioned in this article:
Andre Wyss

Study Finds Vulnerability in Malaria Parasite

Novartis - ... Stephan Meister UCSD), Lucia Rameh (Boston University, Boston), Joerg Trappe (Novartis Institutes for BioMedical Research, Basel, Switzerland), Dorothea Haasen (Novartis, Basel...

Joerg Trappe

Mentioned in this article:
Joerg Trappe

US sues Novartis in NY again, cites doc kickbacks | kens5.com San Antonio

Novartis - Novartis President Andre Wyss said the company disagreed with the way the government characterized its conduct and stands behind its compliance program. "NPC invests significant time and resources to help ensure we conduct our business in an ethical and responsible manner," Wyss ...

Andre Wyss

Mentioned in this article:
Andre Wyss

Drug maker Novartis loses India patent battle | The Daily Reporter

Ranjit Shahani, the vice chairman and managing director of Novartis India, said the ruling “will hinder medical progress for diseases without effective treatment options.” He said the court’s decision made India an even less attractive country for major investments by international ...

Ranjit Shahani

Mentioned in this article:
Ranjit Shahani

Novartis Loses In Patent Court Ruling, India

Ranjit Shahani, Vice Chairman and Managing Director, Novartis India Limited, said: "Novartis has never been granted an original patent for Glivec in India. We strongly believe that original innovation should be recognized in patents to encourage investment in medical innovation ...

Big Pharma waits nervously on Glivec patent verdict - Yahoo! Finance

Ranjit Shahani, vice chairman and managing director of Novartis India Ltd (NOIN.BO), the firm's Indian unit, said cheap generics had an important role to play once drug patents expired, but the company was concerned about the non-recognition of patents that were ultimately needed to ...

Drug maker Novartis loses India patent battle - Silver City Sun-News

Ranjit Shahani, the vice chairman and managing director of Novartis India, said the ruling "will hinder medical progress for diseases without effective treatment options. " He said the court's decision made India an even less attractive country for major investments by international ...

India Says No to Novartis Updated Cancer Drug Patent - Novinite.com - Sofia News Agency

"This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options," said Ranjit Shahani, vice-chairman and managing director of Novartis India. But healthcare campaigners have welcomed the ruling. Glivec, which is used to treat ...

Join Newsle to find out when Ray Trumbo makes the news.

As a Newsle member, you’ll be able to:

  • Get alerts on Ray Trumbo
  • See news articles & blog posts about Ray Trumbo
  • Follow your friends & colleagues in the news
This profile only includes publicly available information. Questions or comments? Contact Us
Freebase CC-BY
Data from Freebase, licensed under CC-BY
Source: CrunchBase
Data from Wikipedia, licensed under the GFDL

People Directory - Browse people by last name:

  1. a
  2. b
  3. c
  4. d
  5. e
  6. f
  7. g
  8. h
  9. i
  10. j
  11. k
  12. l
  13. m
  14. n
  15. o
  16. p
  17. q
  18. r
  19. s
  20. t
  21. u
  22. v
  23. w
  24. x
  25. y
  26. z
  27. more